User menu

The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation.

Bibliographic reference Pecquet, Christian ; Nyga, R ; Penard-Lacronique, V ; Smithgall, T E ; Murakami, H ; et. al. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation.. In: Oncogene : including Oncogene Reviews, Vol. 26, no.11, p. 1577-85 (2007)
Permanent URL http://hdl.handle.net/2078.1/137954
  1. Blake RA, Mol Cell Biol, 20, 9018 (2000)
  2. Briggs SD, J Biol Chem, 270, 14718 (1995)
  3. Carron C, Blood, 95, 3891 (2000)
  4. Cazzaniga G, Blood, 94, 4370 (1999)
  5. Chin H, Blood, 91, 3734 (1998)
  6. Dai Y, J Biol Chem, 279, 34227 (2004)
  7. Danhauser-Riedl S, Cancer Res, 56, 3589 (1996)
  8. Donato NJ, Blood, 101, 690 (2003)
  9. Dos Santos NR, Leukemia, 20, 182 (2005)
  10. Ernst TJ, J Biol Chem, 269, 5764 (1994)
  11. Golub TR, Cell, 77, 307 (1994)
  12. Golub T R, Goga A, Barker G F, Afar D E, McLaughlin J, Bohlander S K, Rowley J D, Witte O N, Gilliland D G, Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia., 10.1128/mcb.16.8.4107
  13. Hanke JH, J Biol Chem, 271, 695 (1996)
  14. Ho JM, Blood, 100, 1438 (2002)
  15. Hu Y, Nat Genet, 36, 453 (2004)
  16. Keung YK, Cancer Genet Cytogenet, 138, 139 (2002)
  17. Klejman A, EMBO J, 21, 5766 (2002)
  18. Knezevich SR, Nat Genet, 18, 184 (1998)
  19. Kuno Y, Blood, 97, 1050 (2001)
  20. Lacronique V, Blood, 95, 2076 (2000)
  21. Lacronique V, Science, 278, 1309 (1997)
  22. Lionberger JM, J Biol Chem, 275, 18581 (2000)
  23. Mao W, Oncogene, 15, 3083 (1997)
  24. Malinge S, Oncogene, 25, 3589 (2006)
  25. Million RP, Blood, 99, 4568 (2002)
  26. Million RP, Mol Cell Biol, 24, 4685 (2004)
  27. Omura T, Eur J Biochem, 269, 381 (2002)
  28. Ottenhoff-Kalff AE, Cancer Res, 52, 4773 (1992)
  29. Papadopoulos P, TEL Cancer Res, 55, 34 (1995)
  30. Peeters P, Blood, 90, 2535 (1997)
  31. Rosa Santos SC, Oncogene, 19, 1164 (2000)
  32. Rosen N, J Biol Chem, 261, 13754 (1986)
  33. Santos SC, FEBS Lett, 497, 148 (2001)
  34. Schindler T, Science, 289, 1938 (2000)
  35. Schwaller J, EMBO J, 17, 5321 (1998)
  36. Spiekermann K, Exp Hematol, 30, 262 (2002)
  37. Stanglmaier M, Leukemia, 17, 283 (2003)
  38. Talamonti MS, J Clin Invest, 91, 53 (1993)
  39. Tatton L, J Biol Chem, 278, 4847 (2003)
  40. Tatosyan AG, Biochemistry (Moscow), 65, 49 (2000)
  41. Tilbrook PA, Cancer Res, 61, 2453 (2001)
  42. Van Limbergen H, Genes Chromosomes Cancer, 30, 274 (2001)
  43. Voss J, Oncogene, 19, 1684 (2000)
  44. Warmuth M, J Biol Chem, 272, 33260 (1997)
  45. Warmuth M, Blood, 101, 664 (2003)
  46. Wilson MB, Oncogene, 21, 8075 (2002)